| |
| |
|
| Insider
Information: |
Castelli Jeff |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
377,205 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,002,145 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
377,205 |
|
|
| Total
Value |
$4,002,145 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-01-09 |
377,205 |
2014-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Chief Development OfficerOffic |
• – – |
2022-12-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
304,255 |
|
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2023-12-20 |
4 |
S |
$13.10 |
$21,667 |
D/D |
(1,654) |
358,082 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2024-01-04 |
4 |
D |
$13.44 |
$42,027 |
D/D |
(3,127) |
372,805 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2015-01-05 |
4 |
AS |
$9.00 |
$42,003 |
D/D |
(4,667) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2015-01-05 |
4 |
OE |
$9.00 |
$42,003 |
D/D |
4,667 |
54,667 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2023-01-03 |
4 |
D |
$11.93 |
$76,483 |
D/D |
(6,411) |
354,581 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Program Management |
• – – |
2015-06-15 |
4 |
AS |
$14.17 |
$104,532 |
D/D |
(7,377) |
0 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Program Management |
• – – |
2015-05-08 |
4 |
D |
$10.80 |
$82,328 |
D/D |
(7,623) |
17,377 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2024-01-02 |
4 |
D |
$14.24 |
$114,461 |
D/D |
(8,038) |
390,015 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2014-11-25 |
4 |
AB |
$8.00 |
$64,824 |
D/D |
8,103 |
58,103 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2014-11-25 |
4 |
AS |
$8.00 |
$64,824 |
D/D |
(8,103) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2014-10-03 |
4 |
AB |
$7.00 |
$59,864 |
D/D |
8,552 |
58,552 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2014-10-03 |
4 |
AS |
$7.00 |
$59,864 |
D/D |
(8,552) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2023-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,643 |
377,236 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2015-04-01 |
4 |
AS |
$10.69 |
$101,480 |
D/D |
(9,489) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2015-04-01 |
4 |
OE |
$10.69 |
$101,480 |
D/D |
9,489 |
59,489 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Program Management |
• – – |
2015-05-11 |
4 |
AS |
$10.84 |
$108,371 |
D/D |
(10,000) |
7,377 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2024-01-09 |
4 |
D |
$13.65 |
$136,568 |
D/D |
(10,005) |
362,800 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2024-01-09 |
4/A |
D |
$13.65 |
$136,568 |
D/D |
(10,005) |
377,205 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2014-10-02 |
4 |
AS |
$6.01 |
$61,303 |
D/D |
(10,208) |
50,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP, Program Management |
• – – |
2014-10-02 |
4 |
AB |
$6.01 |
$61,303 |
D/D |
10,208 |
60,208 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2023-01-02 |
4 |
D |
$12.21 |
$170,256 |
D/D |
(13,944) |
290,311 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2024-01-03 |
4 |
D |
$13.53 |
$190,543 |
D/D |
(14,083) |
375,932 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2024-01-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,405 |
387,210 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Development Officer |
• – – |
2023-08-17 |
4 |
D |
$12.77 |
$185,931 |
D/D |
(14,560) |
368,593 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
